Showing results (171-180 of 293) with videos related to
Sort By:
Pageof 30
Pediatric Blood & Cancer|January 28, 2021
Mandibular metastases in neuroblastoma: Outcomes and dental sequelaeAnnu Singh, Shakeel Modak, Armand K Solano, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2025
Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Current Tools, Techniques, and Uncharted TerritoriesTahir Yusufaly, Emilie Roncali, Julia Brosch-Lenz, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2025
Lesion Absorbed Dose-Response Relationship in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [<sup>177</sup>Lu]Lu-PSMA-617 Radiopharmaceutical TherapyMilan Grkovski, Simone S Krebs, Joseph A O'Donoghue, et al.European Journal of Nuclear Medicine and Molecular Imaging|June 30, 2019
European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paragangliomaDavid Taïeb, Rodney J Hicks, Elif Hindié, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 3, 2007
Targeting Lewis Y (Le(y)) in small cell lung cancer with a humanized monoclonal antibody, hu3S193: a pilot trial testing two dose levelsLee M Krug, Daniel T Milton, Achim A Jungbluth, et al.Melanoma Research|June 25, 2025
Programmed death ligand-1 PET imaging in patients with melanoma: a pilot studyNeeta Pandit-Taskar, Audrey Mauguen, Denise Frosina, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2010
Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemiaTodd L Rosenblat, Michael R McDevitt, Deborah A Mulford, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 23, 2017
Pharmacokinetics, Biodistribution, and Radiation Dosimetry for <sup>89</sup>Zr-Trastuzumab in Patients with Esophagogastric CancerJoseph A O'Donoghue, Jason S Lewis, Neeta Pandit-Taskar, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 23, 2025
Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Ethical, Regulatory, and Socioeconomic Dimensions of Theranostic Digital TwinsLidia Strigari, Jazmin Schwarz, Tyler Bradshaw, et al.Oncoimmunology|November 18, 2017
Phase I trial of anti-GD2 monoclonal antibody hu3F8 plus GM-CSF: Impact of body weight, immunogenicity and anti-GD2 response on pharmacokinetics and survivalIrene Y Cheung, Brian H Kushner, Shakeel Modak, et al.Pageof 30